Wilton, Angelina R.
Sheffield, Katharine
Wilkes, Quantia
Chesak, Sherry
Pacyna, Joel
Sharp, Richard
Croarkin, Paul E.
Chauhan, Mohit
Dyrbye, Liselotte N.
Bobo, William V.
Athreya, Arjun P.
Funding for this research was provided by:
Mayo Foundation for Medical Education and Research
National Institute of Nursing Research (R01 NR020362, R01 NR020362, R01 NR020362, R01 NR020362, R01 NR020362, R01 NR020362, R01 NR020362)
Article History
Received: 17 May 2023
Accepted: 3 January 2024
First Online: 13 February 2024
Declarations
:
: This study being performed in accordance with the Declaration of Helsinki is approved by Mayo Clinic Institutional Review Board (IRB) and is registered in clinicaltrials.gov as NCT05481138. Informed consent to participate in the study will be obtained from interested participants via email prepared by study coordinators. All amendments to study procedures approved by IRB will be communicated to participants via email.
: Not applicable.
: WVB research has been supported by the National Institute of Mental Health, the Agency for Healthcare Quality and Research, the National Science Foundation, the Myocarditis Foundation, and the Mayo Foundation for Medical Education and Research. He has contributed chapters to UpToDate concerning the pharmacological treatment of adults with bipolar major depression. PEC has received research grant support from Neuronetics, Inc., NeoSync, Inc., and Pfizer, Inc. He has received grant in-kind (equipment, supply, and genotyping support for research studies) from Assurex Health, Neuronetics, Inc., and MagVenture, Inc. PEC has served as a consultant for Engrail Therapeutics, Myriad Neuroscience, Procter & Gamble, and Sunovion. LND is a co-inventor of the Well-Being Index and its derivatives which Mayo Clinic has licensed (outside submitted work). LND receives royalties. All other authors declared no competing interests for this work.